These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28697847)

  • 1. The impact of serum trans fatty acids concentration on plaque vulnerability in patients with coronary artery disease: Assessment via optical coherence tomography.
    Nagasawa Y; Shinke T; Toh R; Ishida T; Otake H; Takaya T; Sugiyama D; Toba T; Kuroda M; Takahashi H; Terashita D; Tahara N; Shinkura Y; Uzu K; Kashiwagi D; Kuroda K; Nagano Y; Yamamoto H; Yanaka K; Tsukiyama Y; Hirata KI
    Atherosclerosis; 2017 Oct; 265():312-317. PubMed ID: 28697847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS.
    Miyamoto Y; Okura H; Kume T; Kawamoto T; Neishi Y; Hayashida A; Yamada R; Imai K; Saito K; Yoshida K
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):638-46. PubMed ID: 21679899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease.
    Tazaki R; Tanigawa J; Fujisaka T; Shibata K; Takeda Y; Ishihara T; Hoshiga M; Hanafusa T; Ishizaka N
    Int Heart J; 2016; 57(1):18-24. PubMed ID: 26673442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic plaque characterization by CT angiography for identification of high-risk coronary artery lesions: a comparison to optical coherence tomography.
    Nakazato R; Otake H; Konishi A; Iwasaki M; Koo BK; Fukuya H; Shinke T; Hirata K; Leipsic J; Berman DS; Min JK
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):373-9. PubMed ID: 25246503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CD14
    Yamamoto H; Yoshida N; Shinke T; Otake H; Kuroda M; Sakaguchi K; Hirota Y; Toba T; Takahashi H; Terashita D; Uzu K; Tahara N; Shinkura Y; Kuroda K; Nagasawa Y; Nagano Y; Tsukiyama Y; Yanaka KI; Emoto T; Sasaki N; Yamashita T; Ogawa W; Hirata KI
    Atherosclerosis; 2018 Feb; 269():245-251. PubMed ID: 29407600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary CT angiography characteristics of OCT-defined thin-cap fibroatheroma: a section-to-section comparison study.
    Yang DH; Kang SJ; Koo HJ; Chang M; Kang JW; Lim TH; Baek S; Han S; Lee PH; Roh JH; Ahn JM; Park DW; Lee SW; Lee CW; Park SW; Park SJ; Mintz GS; Kim YH
    Eur Radiol; 2018 Feb; 28(2):833-843. PubMed ID: 28836052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography.
    Liu X; Xie Z; Sun M; Wang X; Li J; Cui J; Zhang F; Yin L; Huang D; Hou J; Tian J; Yu B
    Int J Cardiol; 2018 Aug; 265():18-23. PubMed ID: 29729869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial Hyperchylomicronemia and Thin-Cap Fibroatheroma in Nonculprit Lesions.
    Kurihara O; Okajima F; Takano M; Kato K; Munakata R; Murakami D; Miyauchi Y; Emoto N; Sugihara H; Seino Y; Shimizu W
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1940-1947. PubMed ID: 29930008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients With Coronary Artery Disease in Japan.
    Mori K; Ishida T; Yasuda T; Hasokawa M; Monguchi T; Sasaki M; Kondo K; Nakajima H; Shinohara M; Shinke T; Irino Y; Toh R; Nishimura K; Hirata K
    Circ J; 2015; 79(9):2017-25. PubMed ID: 26166015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography.
    Yonetsu T; Kato K; Uemura S; Kim BK; Jang Y; Kang SJ; Park SJ; Lee S; Kim SJ; Jia H; Vergallo R; Abtahian F; Tian J; Hu S; Yeh RW; Sakhuja R; McNulty I; Lee H; Zhang S; Yu B; Kakuta T; Jang IK
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):665-73. PubMed ID: 23922003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study.
    Tian J; Ren X; Vergallo R; Xing L; Yu H; Jia H; Soeda T; McNulty I; Hu S; Lee H; Yu B; Jang IK
    J Am Coll Cardiol; 2014 Jun; 63(21):2209-16. PubMed ID: 24632266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of optical coherence tomography and intravascular ultrasound for evaluation of coronary lipid-rich atherosclerotic plaque progression and regression.
    Xie Z; Tian J; Ma L; Du H; Dong N; Hou J; He J; Dai J; Liu X; Pan H; Liu Y; Yu B
    Eur Heart J Cardiovasc Imaging; 2015 Dec; 16(12):1374-80. PubMed ID: 25911116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality imaging of attenuated plaque using grayscale and virtual histology intravascular ultrasound and optical coherent tomography.
    Kang SJ; Ahn JM; Han S; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):E1-E11. PubMed ID: 25511369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
    Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
    Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Osue T; Kinutani H; Konishi A; Takahashi H; Terashita D; Uzu K; Hirata K
    Cardiovasc Diabetol; 2015 Jun; 14():78. PubMed ID: 26062762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum n-3 to n-6 polyunsaturated fatty acids ratio correlates with coronary plaque vulnerability: an optical coherence tomography study.
    Hasegawa T; Otsuka K; Iguchi T; Matsumoto K; Ehara S; Nakata S; Nishimura S; Kataoka T; Shimada K; Yoshiyama M
    Heart Vessels; 2014 Sep; 29(5):596-602. PubMed ID: 24005765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low eicosapentaenoic acid to arachidonic acid ratio is associated with thin-cap fibroatheroma determined by optical coherence tomography.
    Wakabayashi Y; Funayama H; Ugata Y; Taniguchi Y; Hoshino H; Ako J; Momomura S
    J Cardiol; 2015 Dec; 66(6):482-8. PubMed ID: 25805011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iMap-Intravascular Ultrasound Radiofrequency Signal Analysis Reflects Plaque Components of Optical Coherence Tomography-Derived Thin-Cap Fibroatheroma.
    Koga S; Ikeda S; Miura M; Yoshida T; Nakata T; Koide Y; Kawano H; Maemura K
    Circ J; 2015; 79(10):2231-7. PubMed ID: 26289833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
    Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.